[HTML][HTML] New versus old: the impact of changing patterns of inhaled corticosteroid prescribing and dosing regimens in asthma management

D Singh, G Garcia, K Maneechotesuwan… - Advances in …, 2022 - Springer
Inhaled corticosteroid (ICS)-containing therapies are the mainstay of pharmacological
management of asthma. They can be administered alone or in combination with a long …

[HTML][HTML] Efficacy of umeclidinium/vilanterol versus umeclidinium and salmeterol monotherapies in symptomatic patients with COPD not receiving inhaled …

F Maltais, L Bjermer, EM Kerwin, PW Jones… - Respiratory …, 2019 - Springer
Background Prospective evidence is lacking regarding incremental benefits of long-acting
dual-versus mono-bronchodilation in improving symptoms and preventing short-term …

Defining the “frequent exacerbator” phenotype in COPD: a hypothesis-free approach

O Le Rouzic, N Roche, AB Cortot, I Tillie-Leblond… - Chest, 2018 - Elsevier
Background The COPD “frequent exacerbator” phenotype is usually defined by at least two
treated exacerbations per year and is associated with a huge impact on patient health …

Annual direct medical cost of active systemic lupus erythematosus in five European countries

A Doria, Z Amoura, R Cervera… - Annals of the …, 2014 - ard.bmj.com
Objectives To evaluate the annual direct medical cost of managing adult systemic lupus
erythematosus (SLE) patients with active autoantibody positive disease in Europe. Methods …

Future concepts in bronchodilation for COPD: dual-versus monotherapy

D Singh, JF Donohue, IH Boucot… - European …, 2021 - Eur Respiratory Soc
Most patients with COPD are recommended to initiate maintenance therapy with a single
long-acting bronchodilator, such as a long-acting muscarinic antagonist or long-acting β2 …

[HTML][HTML] Control of asthma in children: still unacceptable? A French cross-sectional study

J de Blic, I Boucot, C Pribil, J Robert, D Huas… - Respiratory …, 2009 - Elsevier
BACKGROUND: The goal of asthma management focuses on adequate control of asthma,
although little is known about the optimal level of asthma control to be reached. The ELIOS …

Evaluation of nasopharyngeal cultures for bacteriologic assessment of acute otitis media in children

P Gehanno, G Lenoir, B Barry, J Bons… - The Pediatric …, 1996 - journals.lww.com
Background The recent emergence of penicillin-resistant Streptococcus pneumoniae,
particularly in acute otitis media (AOM), has increased interest in the development of …

[HTML][HTML] Primary care management of asthma exacerbations or attacks: impact of the COVID-19 pandemic

M Fletcher, T van der Molen, W Lenney, I Boucot… - Advances in …, 2022 - Springer
The COVID-19 pandemic has brought a renewed focus on appropriate management of
chronic respiratory conditions with a heightened awareness of respiratory symptoms and the …

Effectiveness versus efficacy trials in COPD: how study design influences outcomes and applicability

A Woodcock, I Boucot, DA Leather… - European …, 2018 - Eur Respiratory Soc
Guidelines for chronic obstructive pulmonary disease (COPD) management are based
largely on results from double-blind randomised controlled trials (RCTs) of efficacy. These …

Comparative efficacy and safety of four-day cefuroxime axetil and ten-day penicillin treatment of group A beta-hemolytic streptococcal pharyngitis in children

Y Aujard, I Boucot, N Brahimi, D Chiche… - The Pediatric …, 1995 - journals.lww.com
In a prospective randomized multicenter study, 308 children, ages 2 to 15 years, were
randomized to receive either cefuroxime axetil suspension (N= 152; 20 mg/kg/day twice …